Robert T Abraham Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2009

Regulation of the mTOR signaling pathway: from laboratory bench to bedside and back again.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert T Abraham Research Topics

Disease

42	Neoplasms (Cancer) 01/2021 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2005
6	Hypoxia (Hypoxemia) 01/2010 - 03/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 09/2005
3	Melanoma (Melanoma, Malignant) 07/2015 - 10/2011
2	Hematologic Neoplasms (Hematological Malignancy) 08/2017 - 04/2008
2	Carcinogenesis 07/2014 - 06/2005
2	Inflammation (Inflammations) 07/2014 - 05/2010
2	Starvation 10/2010 - 05/2010
2	Tuberous Sclerosis (Bourneville's Disease) 05/2010 - 01/2009
2	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2004 - 01/2002
1	Parkinson Disease (Parkinson's Disease) 03/2017
1	Liposarcoma 07/2015
1	Retinoblastoma (Glioblastoma, Retinal) 07/2015
1	Obesity 07/2014
1	Tics (Tic) 01/2013
1	Carcinoma (Carcinomatosis) 11/2011
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Hepatitis B 05/2010
1	Pancreatitis 05/2010
1	Glioma (Gliomas) 01/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2009
1	Osteosarcoma (Osteogenic Sarcoma) 05/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2008
1	Squamous Cell Carcinoma of Head and Neck 02/2008

Drug/Important Bio-Agent (IBA)

13	TOR Serine-Threonine KinasesIBA 11/2011 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 05/2013 - 03/2002
8	Phosphotransferases (Kinase)IBA 01/2021 - 01/2002
7	Sirolimus (Rapamycin)FDA Link 01/2010 - 10/2002
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 08/2009
6	MTOR InhibitorsIBA 01/2010 - 06/2007
4	AntigensIBA 05/2013 - 06/2011
3	Immunoconjugates (Immunoconjugate)IBA 05/2013 - 06/2011
3	Pharmaceutical PreparationsIBA 11/2012 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 11/2011 - 12/2009
3	temsirolimus FDA Link 11/2011 - 04/2008
2	palbociclibIBA 01/2021 - 07/2015
2	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2017 - 01/2010
2	UbiquitinIBA 03/2017 - 01/2006
2	Biological ProductsIBA 05/2013 - 09/2007
2	Serine (L-Serine)FDA Link 10/2011 - 03/2002
2	Glucose (Dextrose)FDA LinkGeneric 05/2010 - 09/2005
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2010 - 08/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2009 - 09/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 06/2005
2	PX-866IBA 09/2007 - 09/2005
1	Cytostatic AgentsIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	AntiportersIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Cystine (L-Cystine)IBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	idelalisibIBA 08/2017
1	Protein Isoforms (Isoforms)IBA 08/2017
1	Growth Factor ReceptorsIBA 08/2017
1	NexusIBA 03/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2016
1	ribociclibIBA 07/2015
1	abemaciclibIBA 07/2015
1	CyclinsIBA 07/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2015
1	Cyclin DIBA 07/2015
1	Beclin-1IBA 09/2013
1	Explosive Agents (Explosives)IBA 05/2013
1	A1mcMMAFIBA 01/2013
1	ChemokinesIBA 12/2012
1	Interleukin-8 (Interleukin 8)IBA 12/2012
1	Dextrans (Dextran)FDA Link 11/2011
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2011
1	Texas redIBA 11/2011
1	PhosphoproteinsIBA 11/2011
1	Amino Acids FDA Link 03/2011
1	NitrogenIBA 03/2011
1	Glutamine (L-Glutamine)FDA Link 03/2011
1	CarbonIBA 03/2011
1	trans-sodium crocetinate (crocetin)IBA 05/2010
1	PPAR gammaIBA 05/2010
1	ethyl pyruvateIBA 05/2010
1	AsbestosIBA 05/2010
1	SteroidsIBA 05/2010
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 03/2010
1	WYE 125132IBA 01/2010
1	Antineoplastic Agents (Antineoplastics)IBA 01/2010
1	Bevacizumab (Avastin)FDA Link 01/2010
1	ChromatinIBA 09/2009
1	CamptothecinIBA 08/2009
1	WYE-354IBA 08/2009
1	Small Interfering RNA (siRNA)IBA 05/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2008

Therapy/Procedure

18	Therapeutics 01/2021 - 08/2002
1	Immunotherapy 01/2019
1	Precision Medicine 05/2014
1	Biological Therapy 05/2010
1	Oral Administration 01/2010